MADRID—Systemic lupus erythematosus (SLE) experts in North America and Europe are working together to refine the classification system for the disease, with the goal of producing a new set of criteria that is simpler to use and more scientifically rigorous than any classification approach previously published, speakers involved with the process said at the 2017…
As questions about biosimilar medications swirl among U.S. rheumatologists, a recently released report sheds some light on the European experience with biosimilars—and may offer some important insights for the U.S. market. The report, Biosimilars in the EU: Information Guide for Healthcare Professionals, was released in late April by the European Medicines Agency (EMA) and the…
Editor’s note: The new Pillar Talk column is developed by the ARHP Executive Committee in an effort to share information about ongoing activities related to our four pillars: Education, Practice, Research and Advocacy. The ARHP Research Subcommittee is committed to promoting research and enhancing research opportunities for health professionals and researchers working in rheumatology. A…
The ACR Early Career Investigators (ECI) Subcommittee has organized two sessions at the 2017 ACR/ARHP Annual Meeting in San Diego. These sessions are devoted to serving the needs of early career investigators including junior faculty, fellows, graduate students and post-docs. Both sessions provide unique opportunities to optimize the research landscape for early career investigators. Mentoring…
Connect with colleagues at the Basic Research Conference (BRC) and the Clinical Research Conference (CRC) pre-meeting courses at the 2017 ACR/ARHP Annual Meeting! The ACR has an exceptional array of research leaders lined up for this year’s BRC and CRC courses on Friday, Nov. 3, and Saturday, Nov. 4, in San Diego. Get ready to…
The ACR Rheumatology Research Workshop (RRW) is a two-day meeting designed to promote interactions between early and established investigators to foster collaboration and facilitate career mentoring. The RRW is targeted to rheumatology fellows, junior faculty, medical/graduate students, and residents interested in learning more about how to succeed in a research career for rheumatology. RRW is…
The Rheumatology Research Foundation and the ACR are committed to advancing the future of rheumatology to support patients living with rheumatic diseases. These organizations are focused on addressing one of the most critical issues facing patients and rheumatology today—the growing shortage of rheumatology professionals. The ACR’s 2015 Workforce Study revealed the dire need for support…
Treat-to-target is a widely used approach for rheumatoid arthritis, in which rheumatologists prescribe treatments to reach established benchmarks of disease activity.1 Is it time for a similar approach for fibromyalgia treatment, even though its pathogenesis, disease-activity measures and treatment algorithms are less well understood? Three fibromyalgia researchers present their case in a new paper, “Treat-to-Target…
Wider awareness and understanding of the more than 100 different rheumatic diseases is a vital element in our work as rheumatologists and rheumatology health professionals. Stimulating interest and engagement among lawmakers, patient groups and the public at large is essential to successful advocacy efforts, as well as the overall future of our specialty. This September,…
MADRID—Determining what is a best practice in rheumatology and then implementing improvements based on what you find can be fraught with complexity, an expert said during the 2017 Annual European Congress on Rheumatology (EULAR). Examples are emerging of benchmarking projects in which electronic registers are used to improve patient care, said William Dixon, MD, chair…